BVI Acquires Benz Research & Development and SpecialEyes

October 15, 2020

BVI, a PE-backed global ophthalmic medical device company, has acquired Benz Research & Development and its customized contact lens subsidiary SpecialEyes, both based in Sarasota, Florida. The deal expands BVI's intraocular lens (IOL) materials and contact lens capabilities — leveraging Benz's proprietary molding technology and materials (used in 50+ million implants) to increase IOL production scale and end-to-end capability.

Buyers
BVI
Targets
Benz Research & Development, SpecialEyes
Platforms
BVI
Industry
Medical Devices
Location
Florida, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.